Literature DB >> 3054561

Converting-enzyme inhibitors in the treatment of hypertension.

G H Williams1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3054561     DOI: 10.1056/NEJM198812083192305

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  60 in total

1.  Studies with low dose intravenous diacid ACE inhibitor (perindoprilat) infusions in normotensive male volunteers.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1992-08       Impact factor: 4.335

2.  Ambulatory blood pressure monitoring for the evaluation of once-daily ACE inhibition: a comparison study of captopril and enalapril combined with hydrochlorothiazide.

Authors:  A von Pölnitz; H M Lorenz; B Höfling
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

Review 3.  Management of mild hypertension. Selecting an antihypertensive regimen.

Authors:  E J Pérez-Stable
Journal:  West J Med       Date:  1991-01

Review 4.  Newer ACE inhibitors. A look at the future.

Authors:  A Salvetti
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 5.  Antihypertensive medications and depression.

Authors:  M H Beers; L J Passman
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

6.  Pharmacological activity and safety of trandolapril (RU 44570) in healthy volunteers.

Authors:  F De Ponti; C Marelli; L D'Angelo; M Caravaggi; L Bianco; S Lecchini; G M Frigo; A Crema
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).

Authors:  D W Cushman; F L Wang; W C Fung; G J Grover; C M Harvey; R J Scalese; S L Mitch; J M DeForrest
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

8.  Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors.

Authors:  J Pernow; J M Lundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

9.  ACE inhibition versus calcium antagonism in the treatment of mild to moderate hypertension: a multicentre study. Ireland-Netherlands Lisinopril-Nifedipine Study Group.

Authors:  W Hart; R J Clarke
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401

10.  Effect of chronic treatment with enalapril on glucose tolerance and serum insulin in non-insulin-resistant Japanese patients with essential hypertension.

Authors:  T Baba; T Kodama; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.